This document contains survival data from a clinical trial comparing patients with different stages of kidney disease who received implantable cardioverter-defibrillators (ICDs). It lists the number of patients at different risk levels over time for four groups defined by primary or secondary prevention and presence of end-stage renal disease or not. P-values of 0.189 and 0.613 are also reported but not defined.